Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/EYPT

    EyePoint Pharmaceuticals, Inc.(EYPT)

    Biotechnology
    Specialty Pharma
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    52.0
    Insider Trading Score
    Peer Group Scores
    REGN
    78
    FDMT
    55
    EYPT
    52
    CLSDQ
    50
    VYNE
    50
    ABBV
    50
    MGNX
    50
    RGNX
    48
    OCUL
    46
    BCRX
    33
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2026-04-20
    Ribeiro Ramiro
    Chief Medical Officer
    Sale
    -2,437
    -100.00%0
    $15.00$36,555View SEC filing
    2026-03-16
    Duker Jay S.
    President and CEO
    Purchase
    +1,500
    +1.51%100,665
    $13.15$19,724View SEC filing
    2026-03-05
    Ribeiro Ramiro
    Chief Medical Officer
    Sale
    -2,438
    -100.00%0
    $17.87$43,572View SEC filing
    2026-02-18
    Ribeiro Ramiro
    Chief Medical Officer
    Sale
    -2,437
    -100.00%0
    $15.00$36,555View SEC filing
    2026-01-07
    Ribeiro Ramiro
    Chief Medical Officer
    Sale
    -42,544
    -100.00%0
    $17.10$727,319View SEC filing
    2025-12-08
    Cormorant Asset Management, LP
    Other
    Sale
    -60,000
    -0.72%8,265,000
    $15.70$942,240View SEC filing
    2025-12-05
    Lurker Nancy
    Director
    Sale
    -9,300
    -4.31%206,547
    $15.11$140,477View SEC filing
    2025-12-01
    Lurker Nancy
    Director
    Sale
    -700
    -0.32%215,847
    $14.95$10,465View SEC filing
    2025-11-12
    Ribeiro Ramiro
    Chief Medical Officer
    Sale
    -2,722
    -100.00%0
    $11.61$31,602View SEC filing
    2025-05-19
    Zaderej Karen L.
    Director
    Purchase
    +10,000
    +37.74%36,500
    $5.90$59,000View SEC filing
    2025-05-15
    Zaderej Karen L.
    Director
    Purchase
    +10,000
    +60.61%26,500
    $5.45$54,450View SEC filing
    2024-08-21
    DICICCO WENDY F
    Director
    Purchase
    +2,567
    +34.69%9,967
    $7.79$19,997View SEC filing
    2024-08-21
    ANDO GORAN
    Director
    Purchase
    +5,000
    +61.35%13,150
    $7.95$39,750View SEC filing
    2024-08-21
    Zaderej Karen L.
    Director
    Purchase
    +12,500
    +312.50%16,500
    $7.98$99,750View SEC filing
    2024-08-20
    Lurker Nancy
    Director
    Purchase
    +3,173
    +3.36%97,635
    $7.88$25,003View SEC filing
    2024-07-16
    GUYER DAVID R
    Director
    Sale
    -11,625
    -86.27%1,850
    $10.06$116,995View SEC filing
    2024-06-04
    GUYER DAVID R
    Director
    Sale
    -11,625
    -75.86%3,700
    $10.30$119,705View SEC filing
    2024-05-16
    GUYER DAVID R
    Director
    Sale
    -11,625
    -67.69%5,550
    $12.65$147,045View SEC filing
    2024-05-08
    Cormorant Asset Management, LP
    10% Owner
    Purchase
    +850,000
    +11.37%8,325,000
    $11.86$10,081,721View SEC filing
    2024-04-22
    Cormorant Asset Management, LP
    10% Owner
    Purchase
    +581,765
    +8.44%7,475,000
    $18.03$10,489,446View SEC filing
    2024-02-05
    Jones David Scott
    SVP & Chief Commercial Officer
    Sale
    -209
    -0.55%37,962
    $28.49$5,954View SEC filing
    2024-01-30
    Paggiarino Dario A.
    Chief Medical Officer
    Sale
    -49,325
    -57.47%36,505
    $25.66$1,265,539View SEC filing
    2024-01-29
    Jones David Scott
    SVP & Chief Commercial Officer
    Sale
    -26,017
    -40.66%37,962
    $25.38$660,370View SEC filing
    2024-01-29
    Paggiarino Dario A.
    Chief Medical Officer
    Sale
    -600
    -1.62%36,505
    $25.00$15,000View SEC filing
    2024-01-26
    Jones David Scott
    SVP & Chief Commercial Officer
    Sale
    -11,900
    -22.94%37,962
    $25.01$297,621View SEC filing

    1-25 of 81

    Page 1 of 4